Internal chain cleavage and product heterogeneity during Edman degradation of isosteric peptide analogs lacking the α-carbonyl function  by Hempel, John et al.
Volume 194, number 2 FEBS 3222 January 1986 
Internal chain cleavage and product heterogeneity during 
Edman degradation of isosteric peptide analogs lacking the 
a-carbonyl function 
John Hempel, Klas Nilsson +, Krister Larsson+ and Hans J&mvall* 
Department of Chemistry I, Karolinska institutet S-104 01 Stockholm and +Ferring AB, S-200 62 MalmB, Sweden 
Received 28 October 1985 
A synthetic peptide analog, with one peptide carbonyl group replaced by a methylene bridge, was submitted 
to structural analysis by Edman degradation Multiple cleavages were obtained in the first cycle, due to 
phenylthiocarbamylation of the internal secondary amine as well as spontaneous alkaline cyclization and 
subsequent recoupling with the Edman reagent. Three fragments from cleavage of the peptide analog after 
a single Edman cycle were purified by reverse-phase high-performance liquid chromatography. The results 
support previous observation; in a novel combination. The reactions may also be important with native 
polypeptides ince non-quantitative alkaline cyclization now encountered can mimic apparent N-terminat 
heterogeneity in agreement with earlier data, while quantitative cyclization can mimic loss of N-terminat 
residues. 
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1. INTRODUCTION 
A search to devise inhibitors of the protease 
renin led to the synthesis of ‘isosteric’ [l] peptide 
analogs with a methylene group replacing the LY- 
carbonyl function of one or more residues. The in- 
hibitory potency of these compounds has been at- 
tributed to an approximation of the enzymatic 
transition state when bound to the protease [2]. 
Structural analysis of such analogs presents inter- 
pretational problems which reflect infrequently en- 
countered reactions that may also be of impor- 
tance in Edman degradations of native proteins. 
Thus, if such an isosteric analog is exposed to 
the Edman reagent, phenylisothiocyanate [3], 
coupling at both the amino-terminus and the 
isosteric, internal N-alkyl site will occur. The 
subsequent cyclization step in acid will then effect 
cleavage of the internal peptide bond involving the 
* To whom correspondence should be addressed 
carbonyl group of the N-alkylated residue, in addi- 
tion to elimination of the original N-terminal 
amino acid as a thiazolinone derivative. Further- 
more, Edman-coupled N-alkyl amino-termini of 
polypeptides have been reported to undergo 
cyclization and cleavage already in the alkaline 
coupling medium [4,5], This reaction will therefore 
produce elimination of more than one residue at 
the first cycle of Edman degradation, yielding a 
heterogeneous product. 
Results from analysis of an isosteric peptide 
analog are now reported, and illustrate the 2 infre- 
quently encountered reactions (internal phenyl- 
thiocarbamylation + cyclization under basic con- 
ditions) in a novel combination, The resulting 
products also confirm previous observations on 
apparent N-terminal heterogeneities of some pro- 
teins [4] and support similar explanations [6] for 
still further proteins [7]. It appears possible that 
the incidence of W-alkylation may be greater than 
its frequency of detection. 
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Table 1 
January 1986 
Results from amino acid analysis after acid hydrolysis of the intact analog and of the 
3 fragments obtained after one step of Edman degradation 
Amino acid 
LYS 
His 
Pro 
Ile 
Leu(R)VaIa 
Phe 
Intact Fragment A Fragment B Fragment C 
1.0 (1) _ 0.8 (1) 1.0 (1) 
3.0 (3) 2.0 (2) 1.0 (1) 1.0 (1) 
2.0 (2) 1.0 (1) - _ 
0.8 (1) _ 1.1 (1) - 
+bU) +c (1) - 
1.0 (1) 1.0 (1) _ - 
N-terminus Pro His Ile His 
a The N-alkylated valine residue is not acid-labile, hence free Val is not detected 
b The isosteric dipeptide itself was seen on analysis of the intact analog, as observed [2] 
’ In fragment A, Edman coupling at the internal secondary amine prevented etection 
of the isosteric dipeptide derivative by the amino acid analysis. However, the 
derivative was indicated by strong absorbance at 280 nm of fraction A in fig.2, but 
not of the intact analog 
The fragments were purified by HPLC as shown in fig.2 and their positions in the in- 
tact peptide are given in fig.1 
2. MATERIALS AND METHODS 
A peptide analog (fig.1) related to the sequence 
of angiotensinogen and with one ‘reduced’* pep- 
tide bond, in which a methylene group replaces the 
carbonyl moiety, was synthesized as described 
[Z,lO] utilizing ~-benzyloxymethyl protection of 
the His side chain [11,12]. All protecting groups 
were removed by single HF cleavage and the com- 
pound was purified by preparative high-perfor- 
* This type of isosteric unit has been referred to as a 
reduced peptide bond (21, even if the nomenclature is 
inadequate. Thus, reduction of a peptide bond would 
yield a -CHOH-NH- unit, which has other properties. 
In the case of acyl imino peptide bonds (X-Pro 
bonds), reduction can initiate cleavage of the bond (cf. 
[8,9]) rather than stabilization against cleavage. 
Second, the -CH2-NH- analogs have been suggested to 
approximate the proteolytic tetrahedral transition 
state [2]. This appears true only in the sense that the 
carbon atom in the carbonyl position is tetrahedrally 
coordinated, but no electrophilic site is presented by 
this carbon atom and an inhibitory effect on a pro- 
tease is likely to be due to non-covalent recognition 
rather than to formation of abortive covalent in- 
termediates. 
mance liquid chromatography on Vydac C,S 
(15-20 pm) using an acetonitrile/O. 1% trifl uoro- 
acetic acid gradient [ 131. The final product yielded 
a single peak on Ultropac ODS TSK 5 pm (LKB 
Products) [ 141. Amino acid compositions were 
determined after 24 h hydrolysis in 6 N HCI/O.S% 
phenol, and N-terminal residues were determined 
by the dansyl method [15]. 
Sequence analysis of the intact analog was per- 
formed by manual degradations with the modified 
Edman reagent 4-N,N-dimethylaminoazobenze-4 ’ - 
isothiocyanate, DABITC 116,171. It was also 
checked in a modified Beckman 89OC liquid-phase 
sequencer [l&19] using a 0.1 M Quadrol buffer 
program in the presence of glycine-precycled 
polybrene to minimize extractive losses. For 
chromatographic separation of cleavage products, 
the analog (40 nmol) was first subjected to a single 
Edman cycle by incubation with 3.3% 
phenylisothiocyanate in 50% pyridine (300 ~1) for 
75 min at 50°C. The mixture was then dried under 
vacuum, treated with anhydrous trifluoroacetic 
acid for 30 min at 5O”C, dried, dissolved in water 
(150 pi), and extracted with butyl acetate (3 x 1 
ml). The aqueous phase was dried, redissolved in 
water, and chromatographed using the same 
HPLC gradient as with the intact analog. 
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3. RESULTS AND DISCUSSION 
3.1. Analytical results 
The amino acid composition of the analog as ob- 
tained after acid hydrolysis is shown in table 1. The 
2-amino-4-methylpentane (Leu(R)) group alkyla- 
ting Val is not released on acid hydrolysis. Dan- 
sylation of the intact analog demonstrated the 
presence of N-terminal Pro. However, at each cy- 
cle of manual or liquid-phase Edman degradation, 
multiple residues were detected (table 2). These 
results indicate reaction with the secondary amine 
of the Leu(R)Val-7 structure and cleavage (reac- 
tion 2, fig.1) already at the alkaline coupling step 
of the degradation by cyclization with the carbonyl 
group of the valyl residue to expose the free amino 
group of Be-8 Edman coupling with Be-8 then 
also occurs in the first cycle (yielding peptide C, 
fig.1). However, PTH-Ile was found to be a 
product also of the second Edman cycle, demon- 
strating that the alkaline cyclization in the first cy- 
cle was not quantitative. Corresponding pairs of 
PTH derivative results were seen in subsequent 
cycles of the degradation (columns B + C, table 2; 
peptides B + C, fig. 1) and all data were consistent 
with the interpretation that 2 internal cleavages 
had occurred during the first cycle of Edman 
degradation. 
3.2. Purification of fragments obtained 
To characterize further the products after the in- 
itial coupling and cleavage in cycle 1, the intact 
peptide (40 nmol) was exposed to the Edman 
reagent in 50% pyridine as described in section 2. 
It was then chromatographed using the same 
HPLC gradient as with the intact analog. Three 
fractions were resolved (fig.2) which gave the 
amino acid compositions shown in table 1, further 
supporting the 2 internal cleavages. Fraction A 
corresponds to the N-terminal part of the analog, 
His-Pro-Phe-His-Leu(R)Val(PTH), but lacks the 
original N-terminal Pro (fig.1). PTH modification 
of the Leu(R)Val structure is indicated by a high 
280 nm absorbance of the peak. Fraction B provid- 
ed the composition (table 1) of the C-terminal part, 
Ile-His-Lys, derived from cleavage after Val-7. 
This fragment corresponds to the material not 
cyclized during the alkaline coupling step, since it 
has N-terminal Ile. Fraction C corresponds to the 
same material except for lack of the Ile. It repre- 
Cycle 
Table 2 
Results of sequence analysis of the intact analog 
Sequencer degradation Interpretation* 
Residue nmol A B C 
1 Pro, Ile 
2 His, Be 
3 Pro, His, Lys 
4 Phe, LYS 
14, 2 Pro-l _b Ile-8 
10, 6 His-2 Ile-8 His-9 
4, 4, 2 Pro-3 His-9 Lys-10 
2, 4 Phe4 Lys-10 - 
a In degradation of the intact analog, an interpretation of the results is necessary since 
3 peptides (A-C) are created in the first cycle and subsequently degraded in mixture. 
However, separate degradation of each peptide after isolation by HPLC purification 
(fig.2) was also carried out and fully proves the assignment interpretations above. 
Low yield of Ile in cycle 1 from the mixture was not observed on degradation of the 
separated peptide C when Be was recovered in full yield equalling that for Be of pep- 
tide B 
b The Edman coupled product of Val-7 was not detected since after one cycle it is still 
linked to Leu(R)-6 
Recoveries were estimated by HPLC of the phenylthiohydantoin derivatives. Residues 
underlined were also detected by manual degradation with the dimeth- 
ylaminoazobenzene isothiocyanate method [16,17], which usually reveals all but the 
last l-2 residues of peptides due to extractive losses [14]. Columns A-C correspond 
to peptides A-C in fig.1, respectively 
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Fig. 1. The peptide analog studied, sites of reaction dur- 
ing one step of Edman degradation, and the fragments 
purified. Vertical arrows (reaction 1) denote sites of 
coupling with phenylisothiocyanate at the free N- 
terminus of Pro-i, the secondary amine of N-alky1 
Vaf-7, and the free amino group of Be-8 @berated by 
atkaiine cyclization, reaction 2). Horizontal arrows in- 
dicate residues removed after conventional cleavage in 
acid (reactian 3). The bent arrow denoting reaction 2 in- 
dicates internal cyclization without liberation of a free 
thiazolinone from that residue, Peptides resulting from 
aft reactions are denoted by the bars A-C, corresponding 
to the columns of tables 1 and 2 and the peaks of fig.2, 
sents the part that cyclized during the alkaline con- 
ditions of the Edman coupling, exposing Be-8 to 
removal by re-coupling and subsequent acid 
cleavage during the same Edman cycle. 
These results were consistent, and are explained 
by cleavage at basic pH, as with N-terminally 
alkylated structures [4,5]. Thus, the reactions can 
occur not only at the amino-terminus but also in- 
ternally as now demonstrated. Cleavage of N- 
terminally alkylated Val in h~mo~obin has been 
reported to be complete within 45 min [S], but the 
reaction with the analog was incomplete after 75 
min, presumably because of steric constraints from 
the internal position. This is consistent with the 
variable rates of the cyclization in the case of dif- 
ferent ribosomd proteins with N-terminal, meth- 
ylated alanine residues 141. 
3.3. Analysis of unconven Eional structures 
The results demonstrate that proof for the struc- 
tures of isosteric peptide analogs can be obtained 
by conventional Edman degradation. Although the 
unconventional part, Leu(R)Val, of the present 
analog was not quantitated upon acid hydrolysis 
(table l), and not passed in the intact analog by an 
Edman step, it was detected as an alkyl analog by 
patterns obtained after single steps of degradation 
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Fig.2. Reverse-phase high-~rformance liquid chroma- 
tography of the fragments obtained after treatment of 
the intact analog with phenylisothiocyanate. The arruw 
denote8 the elution position of the untreated analog, 
demonstrating that after the Edman cycle no peak cor- 
responds to intact materiaf, The dashed line indicates the 
gradient of acetonitrife (%B) in 0.1% tri~uoroaceti~ 
acid. 
(figs 1 and 2, tables 1 and 2). These analytical 
possibilities are important since isosteric peptide 
analogs show promise for different applicatibns 
and may therefore come under analytical scrutiny- 
3 A. N-terminal protein heterogeneity 
The heterogeneity now encountered (overlapping 
peptides B and C, fig-l) as a result of Edman 
degradation of peptide analogs with internally 
positioned N-alkylated residues is also relevant in 
relation to native pol~ptides. Thus, as shown 
before, a similar apparent heterogeneity will result 
from Edman degradations of N-terminally alkyl- 
ated proteins [4]. Some apparent N-terminal pro- 
tein heterogeneities reported in the literature can 
also be derived from initially unrecognized alkaline 
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cyclization and re-coupling during analytical 
degradation rather than from native trimming dif- 
ferences. For example, in the case of a Neisseria 
pili protein [7f, it is probable, as pointed out 
before [6], that spontaneous cleavage of an N- 
terminal, N-methyl Phe during analysis explains 
the apparent trimming of this residue in about 
50% of all chains. 
Fu~hermore, it is important to note that near 
quantitative alkaline cleavage during Edman 
degradation of an N-terminal, iv-methyl amino 
acid residue is also possible (92% cleavage of ZV- 
methyl Ala in [4]), thus raising the possibility that 
complete loss of an alkylated N-terminal residue 
could be encountered uring structural analysis. In 
such an instance, an N-methylated or other N- 
alkylated amino acid would be entirely overlooked 
because of premature cyclization during the alka- 
line coupling, followed by loss in the extraction 
step along with reaction by-products. This is im- 
portant to recognize since N-terminal ~kylations 
occur 14,201, and since protein structures are in- 
creasingly determined by Edman degradation only 
of the intact protein or a few fragments, for selec- 
tion of sequences on which to base nucleotide pro- 
bes for the cDNA, in which case detection of short 
peptides likely to reveal N-terminal alkylations is 
not favored. Unfortunately, however, structures 
with the most common amino-terminal modifica- 
tion, acetylation [21], are not affected by the 
presently discussed reactions and are refractive to 
analysis by direct Edman degradation. 
At the same time as N-terminal heterogeneity is 
now emphasized as a possible sign of analytically 
derived artifacts, it should be noted that true 
heterogeneity from N-terminal proteolytic process- 
ing is also common. Furthermore, in some systems, 
the extent of N-terminal heterogeneity is different 
among isozymes. For example, mitochondrial iso- 
zymes are frequently N-terminally heterogeneous 
whereas corresponding cytosolic ones are not, as 
recently demonstrated in the case of aldehyde 
dehydrogenases [22]. This fact was concluded to 
reflect differential proteolysis of signals for 
mitochondrial transport. In that system, this still 
appears to be the likely explanation, but the pre- 
sent observations raise the possibility that apparent 
N-terminal heterogeneities may in other cases also 
be derived from signals utilizing N-terminal alkyl- 
ation. 
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